Abstract:Background: The American Heart Association recently introduced a new model for cardiovascular health (CVH) known as Life's Essential 8 (LE8). The impact of LE8 on hypertensive individuals is currently unclear. In our study, we investigated the correlation between comprehensive and individual CVH indicators as defined by LE8, and the mortality rates in hypertension patients. Methods: We analyzed a total of 8,448 hypertensive individuals aged ≥ 20 years who participated in the National Health and Nutrition Examination Survey from 2007 to 2016. These participants were nonpregnant and noninstitutionalized. We identified their mortality by linking their data to the National Death Index until December 31, 2019. The overall cardiovascular health (CVH) was assessed using the LE8 score, which ranged from 0 to 100. Additionally, we evaluated the scores for each component of diet, physical activity, tobacco/nicotine exposure, sleep duration, body mass index, non-high-density lipoprotein cholesterol, blood glucose, and blood pressure. The CVH were categorized into low (0-49), moderate (50-79), and high (80-100) CVH. Results: Over an average follow-up period of 7.41 years, 1,482 (17.54%) of the participants died, among which 472 deaths were attributed to CVD. When compared to adults with lower total CVH scores, those with elevated total CVH scores displayed a 37% reduced risk of mortality from all causes (adjusted hazard ratio [aHR] = 0.63, 95% confidence interval [CI] = 0.45-0.88). In relation to CVD-specific mortality, the corresponding aHRs for moderate and high total CVH scores were 0.76 (0.60-0.97) and 0.54 (0.31-0.94), respectively. Furthermore, after adjusting for potential confounders, it was observed that higher scores on the LE8 index were associated with a reduced risk of both all-cause mortality (aHR for every 10-score increase, 0.91; 95% CI = 0.86-0.96) and CVD-specific mortality (aHR for every 10-score increase, 0.82; 95% CI = 0.75-0.90). Notably, a linear dose-response relationship was observed in this association. Similar patterns were identified in the relationship between health behavior and both all-cause and CVD-specific mortality. Conclusions: Achieving a higher CVH score, as per the new LE8 guidelines, has been found to be associated with a reduced risk of mortality from all causes and specifically from CVD in patients with hypertension. Therefore, public health and healthcare initiatives that focus on promoting higher CVH scores could potentially yield significant benefits in terms of reducing mortality rates among individuals with hypertension.

Life's Essential 8 and Heart Failure among Patients with Chronic Kidney Disease: the Kailuan Cohort Study.

Association of life's essential 8 with chronic cardiovascular-kidney disorder: a prospective cohort study

AHA Life's Essential 8 and new-onset CKD: a prospective cohort study from the UK Biobank

Age-dependent interaction between Life's Essential 8 and chronic kidney disease: A national cross-sectional analysis

Association of life's essential 8 with risk of recurrent cardiovascular events among patients with coronary heart disease

Better Life's Essential 8 is Associated with Lower Risk of Diabetic Kidney Disease: A Community‐Based Study

Life's essential 8 and cardiovascular diseases progression among adults in the United Kingdom

Association between new Life's Essential 8 and the risk of all-cause and cardiovascular mortality in patients with hypertension: a cohort study

The impact of cardiovascular health on mortality in US adults with cardiometabolic disease: A prospective nationwide cohort study

Association Between New Life’s Essential 8 and the Risk of All-Cause and Cardiovascular Mortality in Patients with Hypertension: a Cohort Study

Association of life's essential 8 with mortality among the individuals with cardiovascular disease

Association Between Life's Essential 8 Cardiovascular Health Metrics With Cardiovascular Events in the Cardiovascular Disease Lifetime Risk Pooling Project

Life's essential 8 and cardiovascular disease among patients with hyperuricemia: The Kailuan Cohort Study

Life's Essential 8 and Risk of All-Cause Mortality in Individuals with Cardiovascular Diseases: A Prospective Community-Based Study

Association between the American Heart Association's new "Life's Essential 8" metrics and kidney stone

The correlation between Life's essential 8 and cardiovascular disease and mortality in individuals with nonalcoholic fatty liver disease: a cross-sectional study

Association of lifes essential 8 and mortality among adults with and without CVD

Association of Left Ventricular Hypertrophy and Functional Impairment with Cardiovascular Outcomes and Mortality among Patients with Chronic Kidney Disease, Results from the C‐STRIDE Study

Risk Factors and Outcomes Associated With Heart Failure With Preserved and Reduced Ejection Fraction in People With Chronic Kidney Disease

Echocardiographic features of left ventricular dysfunction and outcomes in chronic kidney disease

Life's essential 8, genetic susceptibility, and incident cardiac arrhythmias: a population-based prospective cohort study